SE457082B - Foerfarande foer framstaellning av hydrokloriden av 1-/2-/5-dimetylaminometyl-2-(furylmetyltio)-etyl//-amino-1-metylamino-2-nitroetylen - Google Patents

Foerfarande foer framstaellning av hydrokloriden av 1-/2-/5-dimetylaminometyl-2-(furylmetyltio)-etyl//-amino-1-metylamino-2-nitroetylen

Info

Publication number
SE457082B
SE457082B SE8403717A SE8403717A SE457082B SE 457082 B SE457082 B SE 457082B SE 8403717 A SE8403717 A SE 8403717A SE 8403717 A SE8403717 A SE 8403717A SE 457082 B SE457082 B SE 457082B
Authority
SE
Sweden
Prior art keywords
formula
hydrochloride
base
methylamino
mol
Prior art date
Application number
SE8403717A
Other languages
English (en)
Swedish (sv)
Other versions
SE8403717L (sv
SE8403717D0 (sv
Inventor
E Kasztreiner
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU251583A external-priority patent/HU193497B/hu
Priority claimed from HU251483A external-priority patent/HU193496B/hu
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE8403717D0 publication Critical patent/SE8403717D0/xx
Publication of SE8403717L publication Critical patent/SE8403717L/xx
Publication of SE457082B publication Critical patent/SE457082B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8403717A 1983-07-15 1984-07-13 Foerfarande foer framstaellning av hydrokloriden av 1-/2-/5-dimetylaminometyl-2-(furylmetyltio)-etyl//-amino-1-metylamino-2-nitroetylen SE457082B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU251583A HU193497B (en) 1983-07-15 1983-07-15 Process for preparing sanitidine hydrogen halogenides
HU251483A HU193496B (en) 1983-07-15 1983-07-15 Process for production of basic tioether and it salts i

Publications (3)

Publication Number Publication Date
SE8403717D0 SE8403717D0 (sv) 1984-07-13
SE8403717L SE8403717L (sv) 1985-01-16
SE457082B true SE457082B (sv) 1988-11-28

Family

ID=26317525

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403717A SE457082B (sv) 1983-07-15 1984-07-13 Foerfarande foer framstaellning av hydrokloriden av 1-/2-/5-dimetylaminometyl-2-(furylmetyltio)-etyl//-amino-1-metylamino-2-nitroetylen

Country Status (13)

Country Link
KR (1) KR910007966B1 (de)
AR (1) AR242029A1 (de)
AT (1) AT389873B (de)
CA (1) CA1279328C (de)
CS (1) CS248717B2 (de)
DK (1) DK162525C (de)
ES (1) ES534363A0 (de)
FI (1) FI88157C (de)
MX (1) MX159694A (de)
NO (1) NO842904L (de)
SE (1) SE457082B (de)
SU (1) SU1384197A3 (de)
YU (1) YU45634B (de)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
GB2067991B (en) * 1980-01-08 1983-10-19 Glaxo Group Ltd Process for the preparation of a furan derivative
NO811501L (no) * 1980-05-13 1981-11-16 Crc Ricerca Chim Fremgangsmaate ved fremstilling av etendiaminderivater, samt mellomprodukter for disse
ES8200358A1 (es) * 1980-09-30 1981-11-01 Inke Sa Procedimiento para la obtencion de la n-2-5-(dimetilamino)metil-2-furanil metil tio-n-metil-2-nitro-1,1-etenodiamina .
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
ES8200101A1 (es) * 1980-12-03 1981-10-16 Inke Sa Procedimiento para la obtencion de la n-(2-( ( (5-( (dimeti-lamino)metil)-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1-etenodiamina
ES8200674A1 (es) * 1980-12-13 1981-11-16 Parellada Llauger Miguel Procedimiento para la obtencion de la n-(2-((5-((dimetilami-no)metil)furfuril)tio)etil)-n'- metil -2- nitro-1,1- eteno- diamina
PT74234B (en) * 1980-12-30 1984-01-05 Glaxo Group Ltd Process for the preparation of a furan derivative
DK153841C (da) * 1980-12-30 1989-02-20 Glaxo Group Ltd Fremgangsmaade til fremstilling af ranitidin
EP0059082B1 (de) * 1981-02-20 1985-01-30 Glaxo Group Limited Verfahren zur Herstellung eines Furanderivats
ES501844A0 (es) * 1981-05-02 1982-11-01 Especialidades Farmaco Terape Procedimiento para la obtencion de un compuesto derivado delalcohol furfurilico
AR229878A1 (es) * 1981-05-07 1983-12-30 Glaxo Group Ltd Procedimiento para preparar ranitidina
ES8300732A1 (es) * 1981-06-10 1982-11-01 Lafarquim Procedimiento para la obtencion de derivados de furil metil mercaptano y sus sales de interes farmacologico
ES507360A0 (es) * 1981-11-20 1982-11-16 Especialidades Latinas Medic U Procedimiento de obtencion de n-(2-5-dimetilamino,metil-2-furanil-metil-tio-etil-n'-metil-s-nitro-etano-diamina.
ES508693A0 (es) * 1982-01-13 1982-11-01 Barisintex Sa "procedimiento para la obtencion de derivados de aminoalkilfuranos".
ES8303391A1 (es) * 1982-04-30 1983-02-01 Inke Sa Procedimiento para la obtencion de la n-2-(5-(dimetilanmino)metil-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1-eteno- diamina.
ES8302686A1 (es) * 1982-05-19 1983-02-01 Tabah Papo Marcelo Procedimiento para la obtencion de un nuevo derivado furanico de interes terapeutico.

Also Published As

Publication number Publication date
YU122484A (de) 1986-10-31
FI88157B (fi) 1992-12-31
FI842822A (fi) 1985-01-16
YU45634B (sh) 1992-07-20
CS248717B2 (en) 1987-02-12
MX159694A (es) 1989-08-07
DK162525C (da) 1992-03-30
AR242029A1 (es) 1993-02-26
CA1279328C (en) 1991-01-22
KR910007966B1 (ko) 1991-10-04
FI88157C (fi) 1993-04-13
DK162525B (da) 1991-11-11
SU1384197A3 (ru) 1988-03-23
ATA227284A (de) 1989-07-15
SE8403717L (sv) 1985-01-16
ES8602732A1 (es) 1985-12-01
AT389873B (de) 1990-02-12
KR850001187A (ko) 1985-03-16
FI842822A0 (fi) 1984-07-13
DK345284D0 (da) 1984-07-13
DK345284A (da) 1985-01-16
SE8403717D0 (sv) 1984-07-13
ES534363A0 (es) 1985-12-01
NO842904L (no) 1985-01-16

Similar Documents

Publication Publication Date Title
PL169267B1 (pl) Sposób wytwarzania nowej racemicznej lub optycznie czynnej pochodnej indolu PL PL PL PL PL PL
HU193161B (en) Process for preparing new n-alkyl-norscopines
EP0124476B1 (de) Carboxamide, Verfahren zur Herstellung und pharmazeutische Präparate, die diese enthalten
WO2013014665A1 (en) Intermediate compounds and process for the preparation of lurasidone and salts thereof
EP0060668B1 (de) N-Carboxyalkyl-dipeptid-Derivate und deren Arzneimittel
SE449862B (sv) Substituerade, heterocykliska bensamider, sett att framstella dessa och en faramakologisk komposition
FI80025B (fi) Foerfarande foer framstaellning av blodtryckssaenkande n-piperazinylalkanoylanilider.
CA2146261A1 (en) Sulfonamide derivatives of benzenefused, hydroxy substituted cycloalkyl and heterocyclic ring compounds
WO2018210354A1 (zh) 一种抗痛风药Lesinurad的新型制备方法及其关键中间体
EP0294695A2 (de) Polysauerstoffhaltige Labdan-Derivate, Verfahren zu deren Herstellung und deren Herstellung als Arzneimittel
IL43749A (en) Cyclopropylmethylamine derivatives of n-containing heterocyclic compounds their production and pharmaceutical compositions containing them
PL205444B1 (pl) Sposób wytwarzania soli sodowej kwasu 1-(((1(R)-(3-(2-(7--chloro-2- chinolinylo)-etenylo)fenylo)-3-(2-(1-hydroksy-1- metyloetylo)fenylo)propylo)sulfanylo)metylo)-cyklopropanooctowego
SE457082B (sv) Foerfarande foer framstaellning av hydrokloriden av 1-/2-/5-dimetylaminometyl-2-(furylmetyltio)-etyl//-amino-1-metylamino-2-nitroetylen
WO2003039439A2 (de) Deuterierte pyrazolopyrimidinone sowie diese verbindungen enthaltende arzneimittel
JPS59512B2 (ja) ピラゾ−ル −５− オンカゴウブツ ノ セイゾウホウホウ
HU229135B1 (en) Benzofurane derivatives
HU196054B (en) Process for producing benzamide derivatives and pharmaceutical compositions containing them as active components
SU880251A3 (ru) Способ получени производных тиохромана или их солей
FI63936C (fi) Analogifoerfarande foer framstaellning av 4-amino-2-(4-(fenylsubstituerad alkoxi)piperidino)kinazoliner anvaendbara saosomantihypertensiva medel
US3102123A (en) Analogues of griseofulvin and process by which they are prepared
JPS6355512B2 (de)
CN111039838B (zh) 一种3-乙酰巯基-2-甲基丙酸的制备方法
SE501501C2 (sv) 1-(2-metyl)-1-oxo-3-rodanidopropyl-prolin och ett förfarande för framställning av 1-/(2S)-3-merkapto-metyl-1-oxopropyl/-L-prolin
EP0230127A1 (de) Verfahren zur Herstellung von Nizatidin
CN109251172B (zh) 一种阿立哌唑的合成方法

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8403717-5

Effective date: 19940210

Format of ref document f/p: F